These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10752998)

  • 1. Pyogenic granuloma of the tongue early after allogeneic bone marrow transplantation for multiple myeloma.
    Kanda Y; Arai C; Chizuka A; Suguro M; Hamaki T; Yamamoto R; Yamauchi Y; Matsuyama T; Takezako N; Shirai Y; Miwa A; Iwasaki K; Nasu M; Togawa A
    Leuk Lymphoma; 2000 Apr; 37(3-4):445-9. PubMed ID: 10752998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pyogenic granuloma of the tongue in chronic graft versus host disease].
    Bachmeyer C; Devergie A; Mansouri S; Dubertret L; Aractingi S
    Ann Dermatol Venereol; 1996; 123(9):552-4. PubMed ID: 9615106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Graft-versus-host disease of the tongue.
    Suh JD; Blackwell KE; Nabili V
    Otolaryngol Head Neck Surg; 2009 Feb; 140(2):272-3. PubMed ID: 19201305
    [No Abstract]   [Full Text] [Related]  

  • 4. Bilateral pyogenic granuloma of the tongue in graft-versus-host disease: report of case.
    Wandera A; Walker PO
    ASDC J Dent Child; 1994; 61(5-6):401-3. PubMed ID: 7897014
    [No Abstract]   [Full Text] [Related]  

  • 5. Intraoral pyogenic granuloma after allogeneic bone marrow transplant. Report of three cases.
    Lee L; Miller PA; Maxymiw WG; Messner HA; Rotstein LE
    Oral Surg Oral Med Oral Pathol; 1994 Nov; 78(5):607-10. PubMed ID: 7838468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus infection of the tongue following marrow transplantation.
    Lloid ME; Schubert MM; Myerson D; Bowden R; Meyers JD; Hackman RC
    Bone Marrow Transplant; 1994 Jul; 14(1):99-104. PubMed ID: 7951127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Allogeneic bone marrow transplantation for refractory multiple myeloma: presence of a graft-versus-myeloma effect].
    Nawa Y; Noguchi T; Kojima K; Hara M
    Rinsho Ketsueki; 2001 Jun; 42(6):481-7. PubMed ID: 11505527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graft-versus-host disease, an eight case report and literature review.
    de la Rosa García E; Bologna Molina R; Vega González Tde J
    Med Oral Patol Oral Cir Bucal; 2006 Nov; 11(6):E486-92. PubMed ID: 17072252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of stem cell source on allogeneic stem cell transplantation outcome in hematological malignancies.
    Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Ostojić G; Tatomirovic Z; Ljubenov M; Marjanović S; Malesević M
    Vojnosanit Pregl; 2011 Dec; 68(12):1026-32. PubMed ID: 22352263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility and toxicity of interferon maintenance therapy after allogeneic BMT for multiple myeloma: a pilot study of the EBMT.
    Samson D; Volin L; Schanz U; Bosi A; Gahrtron G
    Bone Marrow Transplant; 1996 May; 17(5):759-62. PubMed ID: 8733694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
    Copelan EA; Biggs JC; Szer J; Thompson JM; Crilley P; Brodsky I; Klein JL; Kapoor N; Harman GS; Avalos BR
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation.
    Jabro G; Koc Y; Boyle T; Schenkein DP; Ravalese J; Wazer D; Miller KB
    Biol Blood Marrow Transplant; 1999; 5(3):173-9. PubMed ID: 10392963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma.
    Reynolds C; Ratanatharathorn V; Adams P; Braun T; Silver S; Ayash L; Carson E; Eisbruch A; Dawson LA; McDonagh K; Ferrara J; Uberti J
    Bone Marrow Transplant; 2001 Apr; 27(8):801-7. PubMed ID: 11477436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Allogenic bone marrow transplantation in multiple myeloma. Analysis of 12 consecutive cases].
    Bladé J; Carreras E; Rozman C; Sierra J; Rovira M; Batlle M; Valls A; Algara M; Marín P; Urbano-Ispizua A
    Med Clin (Barc); 1995 Jun; 105(1):1-4. PubMed ID: 7637408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
    Chan GW; Gorgun G; Miller KB; Foss FM
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.